A BILL 
To amend section 303(g) of the Controlled Substances Act 
(21 U.S.C. 823(g)) to eliminate the separate registration 
requirement for dispensing narcotic drugs in schedule 
III, IV, or V (such as buprenorphine) for maintenance 
or detoxification treatment, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Mainstreaming Addic-
4
tion Treatment Act of 2019’’. 
5
21:19 May 08, 2019
H2482
2 
•HR 2482 IH
SEC. 2. ELIMINATING SEPARATE REGISTRATION REQUIRE-
1
MENT FOR DISPENSING NARCOTIC DRUGS IN 
2
SCHEDULE III, IV, AND V FOR MAINTENANCE 
3
OR DETOXIFICATION TREATMENT. 
4
(a) IN GENERAL.—Section 303 of the Controlled 
5
Substances Act (21 U.S.C. 823) is amended— 
6
(1) by striking paragraph (2) of subsection (g); 
7
and 
8
(2) in subsection (g), as amended— 
9
(A) by striking ‘‘(g)(1) Except as provided 
10
in paragraph (2), practitioners who dispense 
11
narcotic drugs to individuals for maintenance 
12
treatment or detoxification treatment’’ and in-
13
serting ‘‘(g) Practitioners who dispense narcotic 
14
drugs (other than narcotic drugs in schedule 
15
III, IV, or V) to individuals for maintenance 
16
treatment or detoxification treatment’’; 
17
(B) by redesignating subparagraphs (A), 
18
(B), and (C) as paragraphs (1), (2), and (3), 
19
respectively; and 
20
(C) in paragraph (2), as redesignated, by 
21
redesignating clauses (i) and (ii) as subpara-
22
graphs (A) and (B), respectively. 
23
(b) CONFORMING CHANGES.— 
24
(1) Subsections (a) and (d)(1) of section 304 of 
25
the Controlled Substances Act (21 U.S.C. 824) are 
26
21:19 May 08, 2019
H2482
3 
•HR 2482 IH
amended by striking ‘‘303(g)(1)’’ each place it ap-
1
pears and inserting ‘‘303(g)’’. 
2
(2) Section 309A(a)(2) of the Controlled Sub-
3
stances Act (21 U.S.C. 829a) is amended— 
4
(A) in the matter preceding subparagraph 
5
(A), by striking ‘‘the controlled substance is to 
6
be administered for the purpose of maintenance 
7
or 
detoxification 
treatment 
under 
section 
8
303(g)(2)’’ and inserting ‘‘the controlled sub-
9
stance is a narcotic drug in schedule III, IV, or 
10
V to be administered for the purpose of mainte-
11
nance or detoxification treatment’’; and 
12
(B) by striking ‘‘and—’’ and all that fol-
13
lows through ‘‘is to be administered by injection 
14
or implantation;’’ and inserting ‘‘and is to be 
15
administered by injection or implantation;’’. 
16
(3) Section 520E–4(c) of the Public Health 
17
Service Act (42 U.S.C. 290bb–36d(c)) is amended 
18
by striking ‘‘information on any qualified practi-
19
tioner that is certified to prescribe medication for 
20
opioid dependency under section 303(g)(2)(B) of the 
21
Controlled Substances Act’’ and inserting ‘‘informa-
22
tion on any practitioner who prescribes narcotic 
23
drugs in schedule III, IV, or V of section 202 of the 
24
21:19 May 08, 2019
H2482
4 
•HR 2482 IH
Controlled Substances Act for the purpose of main-
1
tenance or detoxification treatment’’. 
2
(4) Section 544(a)(3) of the Public Health 
3
Service Act (42 U.S.C. 290dd–3) is amended by 
4
striking ‘‘any practitioner dispensing narcotic drugs 
5
pursuant to section 303(g) of the Controlled Sub-
6
stances Act’’ and inserting ‘‘any practitioner dis-
7
pensing narcotic drugs for the purpose of mainte-
8
nance or detoxification treatment’’. 
9
(5) Section 1833(bb)(3)(B) of the Social Secu-
10
rity Act (42 U.S.C. 1395l(bb)(3)(B)) is amended by 
11
striking ‘‘first receives a waiver under section 303(g) 
12
of the Controlled Substances Act on or after Janu-
13
ary 1, 2019’’ and inserting ‘‘first begins prescribing 
14
narcotic drugs in schedule III, IV, or V of section 
15
202 of the Controlled Substances Act for the pur-
16
pose of maintenance or detoxification treatment on 
17
or after January 1, 2019’’. 
18
(6) Section 1834(o)(3)(C)(ii) of the Social Se-
19
curity Act (42 U.S.C. 1395m(o)(3)(C)(ii)) is amend-
20
ed by striking ‘‘first receives a waiver under section 
21
303(g) of the Controlled Substances Act on or after 
22
January 1, 2019’’ and inserting ‘‘first begins pre-
23
scribing narcotic drugs in schedule III, IV, or V of 
24
section 202 of the Controlled Substances Act for the 
25
21:19 May 08, 2019
H2482
5 
•HR 2482 IH
purpose of maintenance or detoxification treatment 
1
on or after January 1, 2019’’. 
2
(7) Section 1866F(c)(3) of the Social Security 
3
Act (42 U.S.C. 1395cc–6(c)(3)) is amended— 
4
(A) in subparagraph (A), by inserting 
5
‘‘and’’ at the end; 
6
(B) in subparagraph (B), by striking ‘‘; 
7
and’’ and inserting a period; and 
8
(C) by striking subparagraph (C). 
9
(8) Section 1903(aa)(2)(C) of the Social Secu-
10
rity Act (42 U.S.C. 1396b(aa)(2)(C)) is amended— 
11
(A) in clause (i), by inserting ‘‘and’’ at the 
12
end; and 
13
(B) by striking clause (ii). 
14
SEC. 3. NATIONAL EDUCATION CAMPAIGN. 
15
(a) IN GENERAL.—The Secretary of Health and 
16
Human Services, acting through the Assistant Secretary 
17
for Mental Health and Substance Use, shall conduct a na-
18
tional campaign to educate practitioners with respect to 
19
the elimination of the separate registration requirement 
20
under section 303(g) of the Controlled Substances Act (21 
21
U.S.C. 823(g)), as in effect on the day before the date 
22
of enactment of this Act, for dispensing narcotic drugs in 
23
schedule III, IV, and V for maintenance or detoxification 
24
treatment. 
25
21:19 May 08, 2019
H2482
6 
•HR 2482 IH
(b) REQUIRED COMPONENTS.—The national edu-
1
cation campaign under subsection (a) shall— 
2
(1) encourage practitioners to integrate sub-
3
stance use treatment into their practices; and 
4
(2) include education on publicly available edu-
5
cational resources and training modules that can as-
6
sist practitioners in treating patients with a sub-
7
stance use disorder. 
8
Æ 
21:19 May 08, 2019
H2482
